EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A specific serum lipid signature characterizes patients with glycogen storage disease type Ia

Alessandro Rossi, Margherita Ruoppolo, Roberta Fedele, Francesca Pirozzi, Carmen Rosano, Renata Auricchio, Daniela Melis, Pietro Strisciuglio, Maaike H Oosterveer, Terry G J Derks, Giancarlo Parenti, Marianna Caterino

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2024.100651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Alessandro Rossi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatrics, Department of Translational Medicine, University of Naples "Federico II", Naples, Italy; Section of Metabolic Diseases, Beatri…. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type I, Lipids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycogen storage disease type Ia (GSDIa) is a rare, inherited glucose-6-phosphatase-α (G6Pase-α) deficiency-induced carbohydrate metabolism disorder. Although hyperlipidemia is a hallmark of GSDI, the extent of lipid metabolism disruption remains incompletely understood. Lipidomic analysis was performed to characterize the serum lipidome in patients with GSDIa, by including age- and sex-matched healthy controls and age-matched hypercholesterolemic controls. Metabolic control and dietary information biochemical markers were obtained from patients with GSDIa. Patients with GSDIa showed higher total serum lysophosphatidylcholine (Fold Change, (FC) 2.2, P < 0.0001), acyl-acyl-phosphatidylcholine (FC 2.1, P < 0.0001), and ceramide (FC 2.4, P < 0.0001) levels and bile acid (FC 0.7, P < 0.001), acylcarnitines (FC 0.7, P < 0.001), and cholesterol esters (FC 1.0, P < 0.001) than those of healthy controls, and higher di- (FC 1.1, P < 0.0001; FC 0.9, P < 0.01) and triacylglycerol (FC 6.3, P < 0.0001; FC 3.9, P < 0.01) levels than those of healthy controls and hypercholesterolemic subjects. Both total cholesterol and triglyceride values correlated with Cer (d16:1/22:0), Cer (d18:1/20:0), Cer (d18:1/20:0(OH)), Cer (d18:1/22:0), Cer (d18:1/23:0), Cer (d18:1/24:1), Cer (d18:2/22:0), Cer (d18:2/24:1). Total cholesterol also correlated with Cer (d18:1/24:0), Cer (d18:2/20:0), HexCer (d16:1/22:0), HexCer (d18:1/18:0), and Hex2Cer (d18:1/20:0). Triglyceridelevels correlated with Cer (d18:0/24:1). Alanine aminotransferase values correlated with Cer (d18:0/22:0), insulin with Cer (d18:1/22:1) and Cer (d18:1/24:1), and HDL with hexosylceramide (HexCer) (d18:2/23:0). These results expand on the currently known involvement of lipid metabolism in GSDIa. Circulating Cer may allow for refined dietary assessment compared with traditional biomarkers. Because specific lipid species are relatively easy to assess, they represent potential novel biomarkers of GSDIa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type ILipidsHumansMaleFemaleAdultAdolescentChildYoung AdultLipid MetabolismBiomarkersLipidomicsChild, PreschoolCase-Control Studies

Stichwörter der Autor:innen

bile acidsceramideshyperlipidemialysophosphatidylcholineserum lipidome

Substanzen

LipidsBiomarkers

Autor:innen und Institutionen

  • Section of Pediatrics, Department of Translational Medicine, University of Naples "Federico II", Naples, Italy; Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University…
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy; CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy.
  • CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy.
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy.
  • Section of Pediatrics, Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Zitieren

APA

Rossi, A., Ruoppolo, M., Fedele, R., Pirozzi, F., Rosano, C., Auricchio, R., Melis, D., Strisciuglio, P., Oosterveer, M. H., Derks, T. G. J., Parenti, G., & Caterino, M. (2024). A specific serum lipid signature characterizes patients with glycogen storage disease type Ia. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100651

Vancouver

Rossi A, Ruoppolo M, Fedele R, Pirozzi F, Rosano C, Auricchio R, et al. A specific serum lipid signature characterizes patients with glycogen storage disease type Ia. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100651

BibTeX
@article{Rossi2024,
  author = {Rossi, Alessandro and Ruoppolo, Margherita and Fedele, Roberta and Pirozzi, Francesca and Rosano, Carmen and Auricchio, Renata and Melis, Daniela and Strisciuglio, Pietro and Oosterveer, Maaike H and Derks, Terry G J and Parenti, Giancarlo and Caterino, Marianna},
  title = {A specific serum lipid signature characterizes patients with glycogen storage disease type Ia},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100651}
}
Kostenlos starten →